Response to: Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women (Reed, Clin Oncol 2007;19:588-590).
Adamson
D J A
DJ
Qureshi
S
S
Harbour
R
R
Twaddle
S
S
Kelnar
C
C
Lowe
G D O
GD
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007255:Information Services / Q000458:organization & administration*; D017410:Practice Guidelines as Topic; D012606:Scotland; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab